MedTrace Logo

Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy

NCT04913376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2024-07-03

No results posted yet for this study

Summary

Effectiveness of hilotherapy for the prevention of oxaliplatin-induced peripheral neuropathy and pain in the treatment of gastrointestinal tumors: A randomized controlled trial.

Conditions

  • Quality of Life
  • Chemotherapy-induced Peripheral Neuropathy

Interventions

DEVICE

Hilotherapy

Constant cooling device for hands and feet.

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Annemarie Coolbrandt, PhD · UZ Leuven

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2022-10-25
Completion
2022-10-25

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04913376 on ClinicalTrials.gov